<qa>  What is the CLINICAL TRIAL of DIFFERENT DOSE OF THE IMMSAFETY AND TOLERABILITY CLINICAL TRIAL OF DIFFERENT DOSES OF THE IMMUNOTHERAPEUTIC DRUG MOBILAN M-VM3 AND PLACEBO IN PATIENTS WITH PROSTATE CANCER: 